Point72 Asset Management L.P. 13D and 13G filings for Iovance Biotherapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-02-14 06:16 am Sale |
2023-12-31 | 13G | Iovance Biotherapeutics, Inc. IOVA |
Point72 Asset Management L.P. | 468,821 0.200% |
-7,646,069 (-94.22%) |
Filing |
| 2023-02-17 4:35 pm Purchase |
2023-02-16 | 13G | Iovance Biotherapeutics, Inc. IOVA |
Point72 Asset Management L.P. | 8,114,890 5.000% |
8,114,890 (New Position) |
Filing |